JPH06321515A - High-strength hardenable material - Google Patents
High-strength hardenable materialInfo
- Publication number
- JPH06321515A JPH06321515A JP5115961A JP11596193A JPH06321515A JP H06321515 A JPH06321515 A JP H06321515A JP 5115961 A JP5115961 A JP 5115961A JP 11596193 A JP11596193 A JP 11596193A JP H06321515 A JPH06321515 A JP H06321515A
- Authority
- JP
- Japan
- Prior art keywords
- powder
- curing
- tetracalcium phosphate
- acid
- curable material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 48
- 239000000843 powder Substances 0.000 claims abstract description 61
- GBNXLQPMFAUCOI-UHFFFAOYSA-H tetracalcium;oxygen(2-);diphosphate Chemical compound [O-2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GBNXLQPMFAUCOI-UHFFFAOYSA-H 0.000 claims abstract description 36
- 239000003607 modifier Substances 0.000 claims abstract description 20
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002345 surface coating layer Substances 0.000 claims abstract description 6
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 4
- 239000011575 calcium Substances 0.000 claims abstract description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229920001661 Chitosan Polymers 0.000 claims abstract description 3
- 102000008186 Collagen Human genes 0.000 claims abstract description 3
- 108010035532 Collagen Proteins 0.000 claims abstract description 3
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 3
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 3
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 3
- 229920001436 collagen Polymers 0.000 claims abstract description 3
- 239000011734 sodium Substances 0.000 claims abstract description 3
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 3
- 229920002258 tannic acid Polymers 0.000 claims abstract description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 3
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 3
- 229940033123 tannic acid Drugs 0.000 claims abstract description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract 3
- 239000011591 potassium Substances 0.000 claims abstract 3
- 229910052700 potassium Inorganic materials 0.000 claims abstract 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims abstract 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims abstract 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910052797 bismuth Inorganic materials 0.000 claims abstract 2
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims abstract 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims abstract 2
- 150000001805 chlorine compounds Chemical class 0.000 claims abstract 2
- 150000002222 fluorine compounds Chemical class 0.000 claims abstract 2
- 150000004679 hydroxides Chemical class 0.000 claims abstract 2
- 229910052744 lithium Inorganic materials 0.000 claims abstract 2
- 239000011777 magnesium Substances 0.000 claims abstract 2
- 229910052749 magnesium Inorganic materials 0.000 claims abstract 2
- 229910052718 tin Inorganic materials 0.000 claims abstract 2
- 229910052725 zinc Inorganic materials 0.000 claims abstract 2
- 239000011701 zinc Substances 0.000 claims abstract 2
- 239000010452 phosphate Substances 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 229960005069 calcium Drugs 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 229960003975 potassium Drugs 0.000 claims 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 claims 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims 1
- 239000001354 calcium citrate Substances 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 229960001078 lithium Drugs 0.000 claims 1
- 229940091250 magnesium supplement Drugs 0.000 claims 1
- 239000001508 potassium citrate Substances 0.000 claims 1
- 229960002635 potassium citrate Drugs 0.000 claims 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims 1
- 235000011082 potassium citrates Nutrition 0.000 claims 1
- 235000013772 propylene glycol Nutrition 0.000 claims 1
- 229940083542 sodium Drugs 0.000 claims 1
- 235000011083 sodium citrates Nutrition 0.000 claims 1
- 235000013337 tricalcium citrate Nutrition 0.000 claims 1
- 238000002156 mixing Methods 0.000 abstract description 13
- 238000006243 chemical reaction Methods 0.000 abstract description 8
- 235000021317 phosphate Nutrition 0.000 abstract 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 abstract 1
- 150000004760 silicates Chemical class 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 11
- 239000002253 acid Substances 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 5
- 229910052586 apatite Inorganic materials 0.000 description 5
- 210000000988 bone and bone Anatomy 0.000 description 5
- 238000004898 kneading Methods 0.000 description 5
- -1 malonic acid Chemical class 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 3
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000003479 dental cement Substances 0.000 description 2
- 229910052587 fluorapatite Inorganic materials 0.000 description 2
- 229940077441 fluorapatite Drugs 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 238000003746 solid phase reaction Methods 0.000 description 2
- 238000010671 solid-state reaction Methods 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 229910001422 barium ion Inorganic materials 0.000 description 1
- AYJRCSIUFZENHW-DEQYMQKBSA-L barium(2+);oxomethanediolate Chemical compound [Ba+2].[O-][14C]([O-])=O AYJRCSIUFZENHW-DEQYMQKBSA-L 0.000 description 1
- 229910001451 bismuth ion Inorganic materials 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000075 oxide glass Substances 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- QGWDKKHSDXWPET-UHFFFAOYSA-E pentabismuth;oxygen(2-);nonahydroxide;tetranitrate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O-2].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O QGWDKKHSDXWPET-UHFFFAOYSA-E 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229910001432 tin ion Inorganic materials 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- LRXTYHSAJDENHV-UHFFFAOYSA-H zinc phosphate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LRXTYHSAJDENHV-UHFFFAOYSA-H 0.000 description 1
- 229910000165 zinc phosphate Inorganic materials 0.000 description 1
Landscapes
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Materials For Medical Uses (AREA)
- Dental Preparations (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、骨補填剤、骨セメン
ト、歯科用セメント等に有用な医科用及び歯科用高強度
硬化性材料に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical and dental high strength curable material useful as a bone filling material, bone cement, dental cement and the like.
【0002】[0002]
【従来の技術】リン酸四カルシウムは組成式Ca4(PO4)2O
で表され、水及び酸等の存在下で、生体内の骨及び歯等
の主成分である無機質成分に極めて近似した化合物に容
易に転化する性質を有しているため、生体材料として注
目されている。2. Description of the Related Art Tetracalcium phosphate has the composition formula Ca 4 (PO 4 ) 2 O.
In the presence of water, acid, etc., it has the property of being easily converted into a compound that is extremely similar to the inorganic component that is the main component of bones and teeth in the living body, and thus has attracted attention as a biomaterial. ing.
【0003】かかる化学活性が高く、常温で容易に硬化
する性質を有するリン酸四カルシウムを主成分とする粉
末を含む、人工骨、骨補填材、歯科用セメント等に使用
される硬化性材料を得る方法として、(1)クエン酸、
マロン酸等のTCAサイクル系有機酸の水溶液と混和し
て、硬化性材料を得る方法、(2)生理食塩水、リン酸
緩衝液等の他に体内の組織液に類似した組成配合の水溶
液と混和して、硬化性材料を得る方法、(3)多糖類水
溶液と混和して、硬化性材料を得る方法、(4)不飽和
有機酸の単独重合物または共重合物の水溶液と混和し
て、硬化性材料を得る方法、(5)上記(1)〜(4)
の方法を適宜組み合わせて、硬化性材料を得る方法が提
案されている。A curable material for use in artificial bones, bone filling materials, dental cements, etc., containing a powder containing tetracalcium phosphate as a main component, which has such a high chemical activity that it hardens easily at room temperature. As a method of obtaining, (1) citric acid,
A method of obtaining a curable material by mixing with an aqueous solution of a TCA cycle organic acid such as malonic acid, (2) mixing with an aqueous solution having a composition similar to that of the interstitial fluid in the body in addition to physiological saline, phosphate buffer, etc. To obtain a curable material, (3) a method of mixing with a polysaccharide aqueous solution to obtain a curable material, and (4) a method of mixing with an aqueous solution of a homopolymer or copolymer of an unsaturated organic acid, Method for obtaining curable material, (5) above (1) to (4)
A method of obtaining a curable material by appropriately combining the above methods has been proposed.
【0004】これらの方法により得られる硬化性材料
は、通常粉材と液剤とを組み合わせた粉液型の形態で臨
床家に提供されている。一般に、生体用の硬化性材料
は、臨床家が治療時に粉材と液剤とを練和混合して、ペ
ースト状乃至粘土状とした後、所望する形態で使用でき
る必要があり、且つ治療後には速やかに硬化して、患部
に強固に固定され、優れた生体親和性を発現することが
必要とされる。The curable material obtained by these methods is usually provided to clinicians in the form of a powder liquid type in which a powder material and a liquid agent are combined. In general, a curable material for living body needs to be used in a desired form after a clinician kneads and mixes a powder material and a liquid agent at the time of treatment to form a paste or clay, and after the treatment, It is required to cure rapidly and to be firmly fixed to the affected area, and to exhibit excellent biocompatibility.
【0005】[0005]
【発明が解決しようとする課題】しかしながら、粉材の
主成分であるリン酸四カルシウム粉末は化学活性が非常
に高く、アルカリ性の物質であるため、酸性水溶液と混
和すると激しく反応してきょう雑物の塊となり、適当な
柔らかさを一定時間保持する均一な組成物となることが
困難であり、上記(1)乃至(5)のいずれの方法によ
っても、満足な性能を有する硬化性材料を得ることがで
きない。However, since the tetracalcium phosphate powder, which is the main component of the powder material, has a very high chemical activity and is an alkaline substance, it reacts violently when mixed with an acidic aqueous solution, and it is a contaminant. It is difficult to obtain a uniform composition that retains an appropriate softness for a certain period of time, and a curable material having satisfactory performance can be obtained by any of the methods (1) to (5) above. I can't.
【0006】このため従来、硬化するまでの組成物の物
性を改善するため或いは組成物の硬化時間を遅延させる
目的で、液剤の酸濃度を低くしたり、組成物中の水分含
有量を増加させたりして、治療操作時間を確保するとと
もに、治療時の操作性を改善する等の方法が提案されて
いる。また、粉材においても、アパタイト、リン酸カル
シウム、リン酸一水素カルシウム、リン酸アルカリ塩、
クエン酸塩などを配合して、リン酸四カルシウムの高い
反応活性を抑制する試みもなされている。Therefore, conventionally, in order to improve the physical properties of the composition until it is cured or to delay the curing time of the composition, the acid concentration of the liquid agent is decreased or the water content of the composition is increased. For example, a method has been proposed that secures a treatment operation time and improves operability during treatment. Also in powder materials, apatite, calcium phosphate, calcium monohydrogen phosphate, alkaline phosphate,
Attempts have been made to suppress the high reaction activity of tetracalcium phosphate by adding citrate or the like.
【0007】しかしながら、これらの方法により得られ
る硬化性組成物は、リン酸四カルシウム系硬化組成物と
しての特性を著しく低下させるにも拘わらず、それを補
う程度の硬化反応特性の改善は認められず、満足すべき
性質を備えたリン酸四カルシウム系硬化性材料が実用化
されていないのが現状である。本発明は、このような現
状に鑑みてなされたものであって、硬化反応を制御でき
る高強度の硬化性材料を提供することを目的とする。However, although the curable composition obtained by these methods remarkably deteriorates the properties as a tetracalcium phosphate-based curable composition, it is recognized that the curing reaction property is improved to the extent of compensating for it. At present, no tetracalcium phosphate-based curable material having satisfactory properties has been put into practical use. The present invention has been made in view of the above circumstances, and an object thereof is to provide a high-strength curable material capable of controlling a curing reaction.
【0008】[0008]
【課題を解決するための手段】本発明者らは、上記目的
を達成するため、リン酸四カルシウム系組成物の生体材
料としての特性を損うことなく、優れた硬化反応特性を
示す種々の材料について鋭意検討を行なった結果、二重
構造を有するリン酸四カルシウム粉末を必須成分とする
硬化性材料に、無機系硬化調整剤及び/又は有機系硬化
調整剤を添加配合して、得られた材料を用いる場合は、
従来技術の問題点が実質的に解消乃至大幅に軽減される
ことを知見した。ここで、“二重構造”とは、リン酸四
カルシウム粒子の表面を、生体に対し親和性を有する物
質或いは生体に対し無害な物質、例えばハイドロキシア
パタイト、フッ化アパタイト、炭酸アパタイト、リン酸
八カルシウムにより被覆した構造を意味するものであ
る。[Means for Solving the Problems] In order to achieve the above-mentioned objects, the present inventors have succeeded in achieving various curing reaction characteristics without impairing the characteristics of a tetracalcium phosphate-based composition as a biomaterial. As a result of earnestly examining the material, it was obtained by adding an inorganic curing modifier and / or an organic curing modifier to a curable material containing tetracalcium phosphate powder having a double structure as an essential component. When using different materials,
It has been found that the problems of the prior art are substantially eliminated or significantly reduced. Here, the “double structure” means that the surface of the tetracalcium phosphate particles is a substance having an affinity for the living body or a substance harmless to the living body such as hydroxyapatite, fluorinated apatite, carbonate apatite, octaphosphate. It means a structure coated with calcium.
【0009】すなわち、本発明は、表面被覆層を有し、
かつリン酸四カルシウムを主成分とする粉末を含む硬化
性材料に、無機系硬化調整剤及び/又は有機系硬化調整
剤を添加配合することを特徴とする医科用及び歯科用の
高強度硬化性材料にかかるものである。That is, the present invention has a surface coating layer,
And high-strength curability for medical and dentistry characterized by adding an inorganic curing modifier and / or an organic curing modifier to a curable material containing a powder containing tetracalcium phosphate as a main component. It depends on the material.
【0010】以下に、本発明を構成に基づき詳細に説明
する。本発明にかかる医療用及び歯科用硬化性材料は、
少なくともリン酸四カルシウムを主成分とする粉末(リ
ン酸四カルシウム粉末と呼ぶ)の表面に表面被覆層を有
する、二重構造のリン酸四カルシウム粉末を必須成分と
する硬化性材料と硬化調整剤との組み合わせからなるも
のである。The present invention will be described in detail below based on the structure. The medical and dental curable material according to the present invention,
A curable material and a curing control agent having a dual structure tetracalcium phosphate powder as an essential component, having a surface coating layer on the surface of at least a powder containing tetracalcium phosphate as a main component (referred to as tetracalcium phosphate powder) It is a combination of
【0011】本発明で使用するリン酸四カルシウム粉末
は、如何なる方法で製造されたものであっても良いが、
リン酸四カルシウムの純度が98%以上である高純度品で
あることが望ましい。この様な高純度の粉末は、例え
ば、CaCO3 粉末とCaHPO4・2H2O粉末とを混合し、1250℃
以上で焼成する下記化1の固相反応法により製造するこ
とができる。The tetracalcium phosphate powder used in the present invention may be produced by any method,
A high-purity product in which the purity of tetracalcium phosphate is 98% or more is desirable. Such high-purity powder is obtained, for example, by mixing CaCO 3 powder and CaHPO 4 .2H 2 O powder,
It can be produced by the solid-state reaction method of the following chemical formula 1, which is fired as described above.
【0012】[0012]
【化1】 [Chemical 1]
【0013】また、得られるリン酸四カルシウム粉末の
純度を高めるため、上記化1の固相反応法を実施するに
際し、CaCO3 粉末とCaHPO4・2H2O粉末に更にアルミナ粉
末(Al2O3) を添加し、生成したリン酸四カルシウムを焼
結体とすることにより、リン酸四カルシウムを高純度で
含む粉末が得られる(特開平2−180705号公報) 。ま
た、リン酸四カルシウム粉末の粒子表面を生体親和性を
有する物質、例えばアパタイトで被覆することにより、
さらに高品質のリン酸四カルシウム粉末が得られる(特
開平4−89307 号公報及び特開平4−139050号公報)。In order to increase the purity of the obtained tetracalcium phosphate powder, when carrying out the solid-state reaction method of the above chemical formula 1, CaCO 3 powder, CaHPO 4 .2H 2 O powder, and further alumina powder (Al 2 O 3 ) is added and the produced tetracalcium phosphate is made into a sintered body, whereby a powder containing tetracalcium phosphate in high purity can be obtained (JP-A-2-180705). Further, by coating the particle surface of the tetracalcium phosphate powder with a substance having biocompatibility, for example, apatite,
Further, high quality tetracalcium phosphate powder can be obtained (JP-A-4-89307 and JP-A-4-139050).
【0014】かかる被覆物質は、リン酸四カルシウムと
強い酸性水溶液との反応をやわらげる性質を有する物質
であれば良く、例えばハイドロキシアパタイト、フッ化
アパタイト、炭酸アパタイトがある。この被覆物質でコ
ーティングされたリン酸四カルシウム粉末の粒度は、硬
化体の用途などによって異なり、必ずしも限定されるも
のではないが、通常20μm 以下で、平均5μm 程度に調
製することが使用する上で好ましい。The coating substance may be any substance having a property of softening the reaction between tetracalcium phosphate and a strongly acidic aqueous solution, and examples thereof include hydroxyapatite, fluorapatite and carbonate apatite. The particle size of the tetracalcium phosphate powder coated with this coating substance varies depending on the use of the hardened product and is not necessarily limited, but it is usually 20 μm or less, and an average of about 5 μm is used. preferable.
【0015】本発明で使用する硬化性材料の組成として
は、上記のリン酸四カルシウム粉末以外に、ハイドロキ
シアパタイト粉末、炭酸アパタイト粉末、フッ化アパタ
イト粉末、リン酸三カルシウム粉末、リン酸一水素カル
シウム粉末等を含有していてもよいが、これらの粉末の
量は、50重量%以下であることが望ましい。リン酸四カ
ルシウム粉末が50重量%未満だと練和後の硬化体の物理
的強度が極端に低下したり、硬化不良を起こしたりする
という問題が生じることがあり、好ましくない。リン酸
四カルシウム粉末以外のその他の添加粉末は、周知又は
公知の方法で得られるものの他に、骨粉なども使用でき
る。The composition of the curable material used in the present invention is, in addition to the above-mentioned tetracalcium phosphate powder, hydroxyapatite powder, carbonate apatite powder, fluorapatite powder, tricalcium phosphate powder, calcium monohydrogen phosphate. Powders and the like may be contained, but the amount of these powders is preferably 50% by weight or less. If the content of the tetracalcium phosphate powder is less than 50% by weight, the physical strength of the cured product after kneading may be extremely lowered, or a curing failure may occur, which is not preferable. As the additive powder other than the tetracalcium phosphate powder, bone powder and the like can be used in addition to those obtained by a known or known method.
【0016】本発明で使用する硬化溶液は、TCAサイ
クル系の有機酸が主成分として用いられ、その他に高分
子有機酸や無機酸などを添加してもよい。TCAサイク
ル系有機酸には、クエン酸、酒石酸、リンゴ酸、マロン
酸、イタコン酸、フマル酸、マレイン酸、コハク酸など
があり、これらの群から選ばれた1種を単独で、あるい
は2種以上を混合して使用する。高分子有機酸には、例
えばアクリル酸の単独重合体、アクリル酸とイタコン酸
の共重合体、アクリル酸とフマル酸の共重合体などが含
まれ、無機酸には、例えばリン酸、硝酸、塩酸、硫酸等
が含まれる。The curing solution used in the present invention contains a TCA cycle type organic acid as a main component, and a high molecular weight organic acid or an inorganic acid may be added. TCA cycle organic acids include citric acid, tartaric acid, malic acid, malonic acid, itaconic acid, fumaric acid, maleic acid, succinic acid, etc., one kind selected from these groups, or two kinds The above is mixed and used. The high molecular weight organic acid includes, for example, a homopolymer of acrylic acid, a copolymer of acrylic acid and itaconic acid, a copolymer of acrylic acid and fumaric acid, and the inorganic acid includes, for example, phosphoric acid, nitric acid, Hydrochloric acid, sulfuric acid, etc. are included.
【0017】この様な酸を通常30〜70%程度の純水を溶
媒とする水溶液の形態で、硬化溶液として、粉材と練和
混合することにより硬化体を得ることができる。この練
和混合する時硬化調整剤を更に添加することにより、反
応活性と硬化時間を自由に制御することができる。A hardened product can be obtained by kneading and mixing such an acid with a powder material in the form of an aqueous solution containing usually 30 to 70% pure water as a solvent. The reaction activity and the curing time can be freely controlled by further adding a curing modifier during the kneading and mixing.
【0018】更に、本発明で使用する硬化調整剤には大
別して無機系物質と有機系物質とがある。無機系硬化調
整剤としては、炭酸リチウム、酸化ナトリウム、水酸化
ナトリウム、炭酸ナトリウム、炭酸水素ナトリウム、塩
化ナトリウム、フッ化ナトリウム、リン酸ナトリウム、
リン酸水素ナトリウム、硫酸ナトリウム、水酸化カリウ
ム、炭酸カリウム、塩化カリウム、リン酸水素カリウ
ム、酸化マグネシウム、炭酸マグネシウム、リン酸マグ
ネシウム、硫酸マグネシウム、酸化カルシウム、水酸化
カルシウム、炭酸カルシウム、塩化カルシウム、リン酸
二水素カルシウム、硫酸カルシウム、ピロリン酸カルシ
ウム、酸化バリウム、炭酸バリウム、塩化バリウム、水
酸化アルミニウム、塩化アルミニウム、リン酸アルミニ
ウム、酸化亜鉛、塩化亜鉛、リン酸亜鉛、オキシ塩化ビ
スマス、塩基性硝酸ビスマス、塩化スズ、フッ化スズ、
ケイ酸ナトリウム、ケイフッ化ナトリウム、ケイ酸カル
シウム、アルミノシリケート、シリカゲル、ホウ酸ナト
リウム等が例示され、これらの群から選ばれた少なくと
も1種が用いられる。化合物としては特に限定されない
が、水または酸性水溶液に比較的簡単に溶解し、リチウ
ムイオン、ナトリウムイオン、カリウムイオン、マグネ
シウムイオン、カルシウムイオン、バリウムイオン、ア
ルミニウムイオン、亜鉛イオン、ビスマスイオン、スズ
イオン、フッ化物イオン、塩化物イオン、炭酸(水素)
イオン、リン酸(水素)イオン、硫酸イオン、水酸化物
イオン、水和ケイ酸イオン、ホウ酸イオンの各種イオン
を溶出する物質あるいは化合物であればよく、酸化物ガ
ラスの様な多種の元素を含有する複合物であってもよ
い。Further, the curing modifier used in the present invention is roughly classified into an inorganic substance and an organic substance. As the inorganic curing modifier, lithium carbonate, sodium oxide, sodium hydroxide, sodium carbonate, sodium hydrogen carbonate, sodium chloride, sodium fluoride, sodium phosphate,
Sodium hydrogen phosphate, sodium sulfate, potassium hydroxide, potassium carbonate, potassium chloride, potassium hydrogen phosphate, magnesium oxide, magnesium carbonate, magnesium phosphate, magnesium sulfate, calcium oxide, calcium hydroxide, calcium carbonate, calcium chloride, phosphorus Calcium dihydrogen acid, calcium sulfate, calcium pyrophosphate, barium oxide, barium carbonate, barium chloride, aluminum hydroxide, aluminum chloride, aluminum phosphate, zinc oxide, zinc chloride, zinc phosphate, bismuth oxychloride, basic bismuth nitrate, Tin chloride, tin fluoride,
Sodium silicate, sodium silicofluoride, calcium silicate, aluminosilicate, silica gel, sodium borate, etc. are exemplified, and at least one selected from these groups is used. Although the compound is not particularly limited, it is relatively easily dissolved in water or an acidic aqueous solution, and lithium ion, sodium ion, potassium ion, magnesium ion, calcium ion, barium ion, aluminum ion, zinc ion, bismuth ion, tin ion, fluorine ion Chloride ion, chloride ion, carbonic acid (hydrogen)
Ions, phosphate (hydrogen) ions, sulfate ions, hydroxide ions, hydrated silicate ions, and various ions such as borate ions can be used, as long as they are substances or compounds that elute various ions such as oxide glass. It may be a complex containing.
【0019】また、有機系硬化調整剤としては、エタノ
ール、プロピレングリコール等の水溶性アルコール、コ
ラーゲン、キトサン、タンニン酸及びこれらの誘導体の
他、クエン酸ナトリウムや乳酸カルシウム等のカルボン
酸の種々の金属塩が例示され、これらの群から選ばれた
少なくとも1種が用いられる。As the organic curing modifier, water-soluble alcohols such as ethanol and propylene glycol, collagen, chitosan, tannic acid and their derivatives, as well as various metals such as sodium citrate and calcium lactate and other carboxylic acids. Examples of the salt include at least one selected from these groups.
【0020】これらの硬化調整剤は、粉材に粉末状で混
合及び/又は硬化溶液に溶解する形態で、粉材及び/又
は硬化溶液に予め添加しておくことができる。添加量
は、粉材側あるいは硬化溶液側のどちら側に添加する場
合でも、0.01〜10重量%の範囲が好ましく、両方に添加
する場合でも、合計量で0.01〜10重量%の範囲となるよ
うにする。これらの範囲を下回ると硬化調製効果が発揮
されないことがあり、これらの範囲を上回ると硬化体の
物性が低下することがあるため、好ましくない。These curing modifiers can be added to the powder material and / or the curing solution in advance in the form of being mixed with the powder material in the form of powder and / or dissolved in the curing solution. The addition amount is preferably in the range of 0.01 to 10% by weight when added to either the powder material side or the curing solution side, and when added to both sides, the total amount should be in the range of 0.01 to 10% by weight. To If it is less than these ranges, the curing preparation effect may not be exhibited, and if it exceeds these ranges, the physical properties of the cured product may deteriorate, which is not preferable.
【0021】硬化溶液の酸の総濃度は特に限定されない
が、10〜80重量%の範囲が好ましい。これらの範囲を逸
脱すると硬化調整剤を添加しても硬化時間が制御できな
くなることがある。The total acid concentration of the curing solution is not particularly limited, but is preferably in the range of 10 to 80% by weight. If the amount is out of these ranges, the curing time may not be controlled even if the curing modifier is added.
【0022】本発明による高強度硬化性材料は、上記の
ようにして適宜硬化調整剤を添加した、粉材と硬化溶液
とを練和混合することにより得られる。粉と液との混合
割合は、高強度の硬化体を得るため粉末100 重量部に対
して酸として硬化溶液5〜80部が好ましい。尚、この発
明の目的達成を妨げないならば、上述したもの以外の通
常当業者が使用する材料を含むことが可能である。The high-strength curable material according to the present invention can be obtained by kneading and mixing a powder material and a curing solution to which a curing modifier is appropriately added as described above. The mixing ratio of the powder and the liquid is preferably 5 to 80 parts by weight of the curing solution as an acid with respect to 100 parts by weight of the powder in order to obtain a cured product having high strength. It should be noted that materials other than those described above, which are commonly used by those skilled in the art, may be included as long as the object of the present invention is not hindered.
【0023】[0023]
【実施例】本発明を、次の実施例及び比較例により一層
明確にする。尚、本発明は以下の実施例のみに限定され
るものではない。The present invention will be further clarified by the following examples and comparative examples. The present invention is not limited to the following examples.
【0024】実施例1 表1に示す割合の各材料を使用して、粉材と、硬化溶液
とをそれぞれ調製した。ただし、粉材を製造するのに際
しては、リン酸四カルシウム粉末、ハイドロキシアパタ
イト粉末、リン酸三カルシウム粉末、リン酸一水素カル
シウム粉末を、表1の割合で混合した組成物を用いた。
粉材と硬化溶液とを粉/液比=2.5g/mlで練和混合し、
硬化時間、圧縮強度、稠度を測定した。結果を、同じく
表1に示す。但し、リン酸四カルシウム粉末の表面を、
ハイドロキシアパタイトにより被覆した。Example 1 A powder material and a curing solution were prepared using the respective materials in the proportions shown in Table 1. However, in producing the powder material, a composition obtained by mixing tetracalcium phosphate powder, hydroxyapatite powder, tricalcium phosphate powder, and calcium monohydrogen phosphate powder in the ratio shown in Table 1 was used.
The powder material and the curing solution are kneaded and mixed at a powder / liquid ratio of 2.5 g / ml,
The curing time, compressive strength and consistency were measured. The results are also shown in Table 1. However, the surface of the tetracalcium phosphate powder
Covered with hydroxyapatite.
【0025】[0025]
【表1】 [Table 1]
【0026】実施例2 リン酸四カルシウム粉末88重量%、ハイドロキシアパタ
イト粉末10重量%、フッ化カルシウム粉末2重量%の混
合物からなる粉材と、クエン酸40重量%、ポリアクリル
酸2重量%、リン酸18%の硬化溶液(酸の総量60重量%
の混合酸) を調製し、表2に示す割合の硬化調整剤を添
加した後、両者を粉/液比=2.5g/ml で練和混合し、硬
化時間、圧縮強度、稠度を測定した。結果を、同じく表
2に示す。但し、リン酸四カルシウム粉末の表面を、ハ
イドロキシアパタイトで被覆した。Example 2 A powder comprising a mixture of tetracalcium phosphate powder 88% by weight, hydroxyapatite powder 10% by weight and calcium fluoride powder 2% by weight, citric acid 40% by weight, polyacrylic acid 2% by weight, Hardening solution of 18% phosphoric acid (total amount of acid 60% by weight
The mixed acid) was prepared, and the curing regulator was added in the proportions shown in Table 2. Both were kneaded and mixed at a powder / liquid ratio of 2.5 g / ml, and the curing time, compression strength and consistency were measured. The results are also shown in Table 2. However, the surface of the tetracalcium phosphate powder was coated with hydroxyapatite.
【0027】[0027]
【表2】 [Table 2]
【0028】比較例1 硬化調整剤を用いない他は全て実施例1及び実施例2と
同じ条件で測定を行なった。配合条件及び測定結果を表
3に示す。Comparative Example 1 The measurement was carried out under the same conditions as in Examples 1 and 2 except that no curing modifier was used. Table 3 shows the compounding conditions and the measurement results.
【0029】[0029]
【表3】 [Table 3]
【0030】比較例2 表面被覆層を持たない従来のリン酸四カルシウム粉末を
用いた他は全て実施例1及び実施例2と同じ条件で測定
を行なった。配合条件及び測定結果を表4及び表5に示
す。Comparative Example 2 Measurement was carried out under the same conditions as in Examples 1 and 2 except that the conventional tetracalcium phosphate powder having no surface coating layer was used. The compounding conditions and the measurement results are shown in Tables 4 and 5.
【0031】[0031]
【表4】 [Table 4]
【0032】[0032]
【表5】 [Table 5]
【0033】...
【発明の効果】本発明によれば、僅かな量の硬化調整剤
を添加するのみで硬化反応を制御することができるた
め、添加された硬化調整剤がリン酸四カルシウム自体の
物性に悪影響を及ぼすことがなく、従来、リン酸四カル
シウム粉末の練和混合が実用上不可能であった配合領域
でも操作性よく練和混合することができ、さらに二重構
造を有するリン酸四カルシウム粉末であっても、練和混
合が困難で実用的には使用不可能だった配合領域でも練
和混合が容易になり、高強度の硬化体を得ることができ
る。また、粉/液比や硬化溶液の酸の濃度を従来より高
くすることが可能となり、より高強度の硬化性材料を得
ることができる。According to the present invention, since the curing reaction can be controlled by adding a small amount of the curing modifier, the added curing modifier adversely affects the physical properties of tetracalcium phosphate itself. It is possible to knead and mix with good operability even in a compounding region where it was not practically possible to knead and mix the tetracalcium phosphate powder without affecting, and further, in the tetracalcium phosphate powder having a double structure. Even if it is present, the kneading and mixing becomes easy even in a compounding area where it is difficult to practically use it and a cured product having high strength can be obtained. In addition, the powder / liquid ratio and the acid concentration of the curing solution can be made higher than before, and a curable material having higher strength can be obtained.
【0034】その上、用途目的、治療目的によって材料
の性能を犠牲にすることなく硬化時間を自由に設定する
ことが可能で、生体材料としての応用範囲が拡大すると
いう顕著な効果が得られる。Furthermore, the curing time can be freely set without sacrificing the performance of the material depending on the purpose of use or the purpose of treatment, and the remarkable effect that the range of application as a biomaterial is expanded is obtained.
フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C04B 28/34 Continuation of the front page (51) Int.Cl. 5 Identification number Office reference number FI technical display location C04B 28/34
Claims (3)
ウムを主成分とする粉末を含む硬化性材料に、無機系硬
化調整剤及び/又は有機系硬化調整剤を添加配合するこ
とを特徴とする医科用及び歯科用の高強度硬化性材料。1. An inorganic curing regulator and / or an organic curing regulator is added to a curable material having a surface coating layer and containing a powder containing tetracalcium phosphate as a main component. A high-strength curable material for medical and dental purposes.
トリウム、カリウム、マグネシウム、カルシウム、カリ
ウム、アルミニウム、亜鉛、ビスマス、スズのそれぞれ
の酸化物、水酸化物、フッ化物、塩化物、炭酸塩、リン
酸塩、硫酸塩、ケイ酸塩からなる群から選ばれた少なく
とも一種が用いられることを特徴とする請求項1に記載
の高強度硬化性材料。2. As an inorganic curing modifier, oxides, hydroxides, fluorides, chlorides, carbonates of lithium, sodium, potassium, magnesium, calcium, potassium, aluminum, zinc, bismuth and tin, The high strength curable material according to claim 1, wherein at least one selected from the group consisting of phosphate, sulfate and silicate is used.
キトサン、タンニン酸、エタノール、プロピレングリコ
ール、クエン酸ナトリウム、クエン酸カルシウム、クエ
ン酸カリウム、乳酸カルシウムの少なくとも一種が用い
られることを特徴とする請求項1に記載の高強度硬化性
材料。3. An organic curing regulator, collagen,
The high-strength curable material according to claim 1, wherein at least one of chitosan, tannic acid, ethanol, propylene glycol, sodium citrate, calcium citrate, potassium citrate, and calcium lactate is used.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5115961A JPH06321515A (en) | 1993-05-18 | 1993-05-18 | High-strength hardenable material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5115961A JPH06321515A (en) | 1993-05-18 | 1993-05-18 | High-strength hardenable material |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06321515A true JPH06321515A (en) | 1994-11-22 |
Family
ID=14675423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5115961A Pending JPH06321515A (en) | 1993-05-18 | 1993-05-18 | High-strength hardenable material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06321515A (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001314497A (en) * | 2000-05-02 | 2001-11-13 | Univ Nihon | Biomaterial composition and cured product thereof |
| WO2002006179A1 (en) * | 2000-07-19 | 2002-01-24 | Mitsubishi Materials Corporation | Calcium phosphate cement |
| WO2002068357A1 (en) * | 2001-02-28 | 2002-09-06 | Mitsubishi Materials Corporation | Calcium phosphate cement |
| WO2002079112A1 (en) * | 2001-03-28 | 2002-10-10 | Mitsubishi Materials Corporation | Kneaded product containing calcium phosphate cement and method for preparation thereof |
| WO2006079619A1 (en) * | 2005-01-27 | 2006-08-03 | Ivoclar Vivadent Ag | Coated dental powder |
| JP2008520568A (en) * | 2004-11-16 | 2008-06-19 | スリーエム イノベイティブ プロパティズ カンパニー | Dental filler containing phosphorus-containing surface treatment and compositions and methods thereof |
| CN101856310A (en) * | 2010-06-30 | 2010-10-13 | 北京大学 | A composition for treating dental caries and a method for preparing fluorapatite using the composition |
| KR101357673B1 (en) * | 2012-09-03 | 2014-02-04 | 한국기계연구원 | The scaffold composition for regeneration of hard tissue having magnesium phosphate, scaffold for regeneration of hard tissue comprising the same and preparation methods thereof |
| JP2014028316A (en) * | 2010-02-22 | 2014-02-13 | Okayama Univ | Kit for biological hard tissue adhesion |
| JP2014506812A (en) * | 2011-01-27 | 2014-03-20 | シリム バーハド | Composition containing injectable self-hardening apatite cement |
| US8957126B2 (en) | 2004-11-16 | 2015-02-17 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
| JP2015211810A (en) * | 2014-05-07 | 2015-11-26 | 公立大学法人大阪市立大学 | Self-curing calcium phosphate composition, kit for producing the composition, and production method |
| US10137061B2 (en) | 2004-11-16 | 2018-11-27 | 3M Innovative Properties Company | Dental fillers and compositions including phosphate salts |
| EP4268794A4 (en) * | 2020-12-28 | 2025-07-02 | Kuraray Noritake Dental Inc | Hardenable calcium phosphate dental cement |
-
1993
- 1993-05-18 JP JP5115961A patent/JPH06321515A/en active Pending
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001314497A (en) * | 2000-05-02 | 2001-11-13 | Univ Nihon | Biomaterial composition and cured product thereof |
| WO2002006179A1 (en) * | 2000-07-19 | 2002-01-24 | Mitsubishi Materials Corporation | Calcium phosphate cement |
| WO2002068357A1 (en) * | 2001-02-28 | 2002-09-06 | Mitsubishi Materials Corporation | Calcium phosphate cement |
| WO2002079112A1 (en) * | 2001-03-28 | 2002-10-10 | Mitsubishi Materials Corporation | Kneaded product containing calcium phosphate cement and method for preparation thereof |
| US9233054B2 (en) | 2004-11-16 | 2016-01-12 | 3M Innovative Properties Company | Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof |
| US10137061B2 (en) | 2004-11-16 | 2018-11-27 | 3M Innovative Properties Company | Dental fillers and compositions including phosphate salts |
| US9517186B2 (en) | 2004-11-16 | 2016-12-13 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
| JP2008520568A (en) * | 2004-11-16 | 2008-06-19 | スリーエム イノベイティブ プロパティズ カンパニー | Dental filler containing phosphorus-containing surface treatment and compositions and methods thereof |
| US9414995B2 (en) | 2004-11-16 | 2016-08-16 | 3M Innovative Properties Company | Dental fillers including a phosphorus-containing surface treatment, and compositions and methods thereof |
| US8957126B2 (en) | 2004-11-16 | 2015-02-17 | 3M Innovative Properties Company | Dental compositions with calcium phosphorus releasing glass |
| WO2006079619A1 (en) * | 2005-01-27 | 2006-08-03 | Ivoclar Vivadent Ag | Coated dental powder |
| JP2008528544A (en) * | 2005-01-27 | 2008-07-31 | イボクラー ビバデント アクチエンゲゼルシャフト | Coated dental powder |
| US7901774B2 (en) | 2005-01-27 | 2011-03-08 | Ivoclar Vivadent Ag | Coated dental powders |
| US9474826B2 (en) | 2010-02-22 | 2016-10-25 | National University Corporation Okayama University | Kit for adhering biological hard tissues |
| US9186433B2 (en) | 2010-02-22 | 2015-11-17 | National University Corporation Okayama University | Kit for adhering biological hard tissues |
| JP2014028316A (en) * | 2010-02-22 | 2014-02-13 | Okayama Univ | Kit for biological hard tissue adhesion |
| CN101856310A (en) * | 2010-06-30 | 2010-10-13 | 北京大学 | A composition for treating dental caries and a method for preparing fluorapatite using the composition |
| JP2014506812A (en) * | 2011-01-27 | 2014-03-20 | シリム バーハド | Composition containing injectable self-hardening apatite cement |
| KR101357673B1 (en) * | 2012-09-03 | 2014-02-04 | 한국기계연구원 | The scaffold composition for regeneration of hard tissue having magnesium phosphate, scaffold for regeneration of hard tissue comprising the same and preparation methods thereof |
| JP2015211810A (en) * | 2014-05-07 | 2015-11-26 | 公立大学法人大阪市立大学 | Self-curing calcium phosphate composition, kit for producing the composition, and production method |
| EP4268794A4 (en) * | 2020-12-28 | 2025-07-02 | Kuraray Noritake Dental Inc | Hardenable calcium phosphate dental cement |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0555807B1 (en) | Bone substitute product and method of producing the same | |
| US4902649A (en) | Hard tissue substitute composition | |
| JPH06321515A (en) | High-strength hardenable material | |
| JPH04135562A (en) | Hydraulic calcium phosphate cement | |
| JP2563187B2 (en) | Method for producing calcium phosphate-based cured product | |
| JPS6283348A (en) | Curable composition for medical use | |
| EP1298103B1 (en) | Calcium phosphate cement | |
| JPH10248915A (en) | Calcium phosphate cement curing solution and composition for calcium phosphate cement cured object | |
| JP2505545B2 (en) | Method for curing curable composition | |
| JP2537121B2 (en) | Curable composition | |
| JPS62153204A (en) | Root canal filling material for dental use | |
| JP2563186B2 (en) | Method for producing calcium phosphate-based cured product | |
| EP1302453B1 (en) | Calcium phosphate cement | |
| JP3423951B2 (en) | Calcium phosphate hardened powder | |
| JPS6323671A (en) | Medical curable composition | |
| JPH03112843A (en) | Hydraulic calcium phosphate cement composition | |
| JP2754245B2 (en) | Root canal filling material | |
| JP2742814B2 (en) | Root canal filling material | |
| JP4319280B2 (en) | Calcium phosphate cement powder and calcium phosphate cement composition | |
| JP4116791B2 (en) | Curing time control method of hydration hardening type calcium phosphate paste | |
| JPH04307067A (en) | Composite composition for manufacture of calcium phosphate based hardening body and manufacture of hardening body | |
| JPH085705B2 (en) | Composition for forming high strength cured product | |
| JP4134299B2 (en) | Calcium phosphate cement for living bone reinforcement treatment capable of forming a high-strength hardened body | |
| JP3558680B2 (en) | Method for producing tetracalcium phosphate, tetracalcium phosphate obtained by this method, and cement composition containing this tetracalcium phosphate | |
| JPH0739577A (en) | Calcium phosphate-based curable composition |